Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.26%281.23M | -1.69%249.34M | 3.38%239.73M | 8.11%1B | 7.16%247.76M | 1.47%269.75M | 18.12%253.62M | 7.34%231.9M | -4.50%927.78M | -8.93%231.2M |
| Operating revenue | 4.26%281.23M | -1.69%249.34M | 3.38%239.73M | 8.11%1B | 7.16%247.76M | 1.47%269.75M | 18.12%253.62M | 7.34%231.9M | -4.50%927.78M | -8.93%231.2M |
| Cost of revenue | 3.89%229.82M | -3.60%202.81M | -0.59%198.8M | 7.15%843M | 7.16%211.43M | 0.87%221.21M | 15.88%210.38M | 6.04%199.98M | -10.69%786.75M | -16.80%197.31M |
| Gross profit | 5.90%51.4M | 7.60%46.53M | 28.27%40.94M | 13.47%160.03M | 7.18%36.32M | 4.28%48.54M | 30.44%43.25M | 16.33%31.91M | 55.74%141.02M | 102.92%33.89M |
| Operating expense | 11.91%30.49M | 22.57%28.79M | 25.03%27.71M | 18.24%93.28M | 7.14%20.38M | 22.26%27.25M | 24.79%23.49M | 18.11%22.16M | -2.38%78.89M | -5.10%19.02M |
| Selling and administrative expenses | 6.45%19.54M | 28.28%19.1M | 28.98%18.13M | 32.23%58.08M | 4.12%10.77M | 46.20%18.36M | 45.87%14.89M | 30.02%14.06M | 4.04%43.92M | -5.53%10.34M |
| -Selling and marketing expense | 18.62%6.72M | 11.52%5.79M | 69.46%6.73M | 27.35%18.84M | 247.95%4.15M | -15.28%5.66M | -5.65%5.19M | -26.73%3.97M | -17.90%14.79M | -183.98%-2.81M |
| -General and administrative expense | 1.02%12.83M | 37.24%13.31M | 13.05%11.41M | 34.72%39.24M | -49.65%6.62M | 116.12%12.7M | 106.10%9.7M | 87.01%10.09M | 20.37%29.13M | 72.79%13.15M |
| Depreciation amortization depletion | 23.17%10.95M | 12.68%9.69M | 18.19%9.58M | 0.66%35.21M | 10.75%9.61M | -8.63%8.89M | -0.19%8.6M | 1.91%8.1M | -9.40%34.98M | -4.58%8.68M |
| -Depreciation and amortization | 23.17%10.95M | 12.68%9.69M | 18.19%9.58M | 0.66%35.21M | 10.75%9.61M | -8.63%8.89M | -0.19%8.6M | 1.91%8.1M | -9.40%34.98M | -4.58%8.68M |
| Operating profit | -1.78%20.91M | -10.20%17.74M | 35.62%13.23M | 7.43%66.74M | 7.23%15.94M | -12.23%21.29M | 37.86%19.76M | 12.48%9.75M | 538.47%62.13M | 544.45%14.87M |
| Net non-operating interest income (expenses) | 7.43%-3.09M | 44.08%-1.97M | 46.24%-2.06M | 2.83%-13.06M | 27.04%-2.36M | 8.30%-3.34M | -6.17%-3.53M | -18.36%-3.83M | -50.09%-13.44M | -8.91%-3.24M |
| Non-operating interest expense | -7.43%3.09M | -44.08%1.97M | -46.24%2.06M | -2.83%13.06M | -27.04%2.36M | -8.30%3.34M | 6.17%3.53M | 18.36%3.83M | 50.09%13.44M | 8.91%3.24M |
| Other net income (expenses) | -248.34%-313K | 335.29%360K | 10.94%213K | 95.79%-50K | 45.24%-299K | 114.60%211K | -145.54%-153K | -58.80%192K | -148.65%-1.19M | -191.92%-546K |
| Special income (charges) | -436.46%-1.26M | 470.59%97K | -45.00%-29K | 111.26%354K | 98.56%-15K | 118.26%373K | 140.48%17K | -5.26%-20K | -854.20%-3.15M | -983.05%-1.04M |
| -Less:Restructuring and mergern&acquisition | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --2.21M | --0 |
| -Gain on sale of property,plant,equipment | -275.60%-655K | 470.59%97K | -45.00%-29K | 137.86%354K | 98.56%-15K | 123.35%373K | 140.48%17K | -5.26%-20K | -324.22%-935K | -983.05%-1.04M |
| Income before tax | -3.61%17.51M | 0.32%16.13M | 86.13%11.38M | 12.91%53.64M | 19.84%13.28M | -5.26%18.17M | 41.71%16.08M | 3.63%6.11M | 1,375.28%47.5M | 293.52%11.08M |
| Income tax | -5.05%4.57M | 10.11%4.31M | 64.46%2.76M | 37.65%16.1M | 104.16%5.7M | -8.87%4.81M | 62.45%3.92M | 37.68%1.68M | 2,462.42%11.69M | 197.76%2.79M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 68.88%12.95M | 30.15%11.82M | 341.78%8.62M | -24.89%20.09M | 2,382.18%6.92M | -44.75%7.67M | 6.90%9.08M | -176.16%-3.57M | 620.05%26.75M | 89.45%-303K |
| Net income continuous operations | -3.09%12.95M | -2.83%11.82M | 94.32%8.62M | 4.83%37.54M | -8.53%7.58M | -3.89%13.36M | 36.12%12.16M | -5.23%4.44M | 863.93%35.81M | 388.68%8.29M |
| Net income discontinuous operations | --0 | --0 | --0 | -92.57%-17.45M | 92.22%-669K | -22,672.00%-5.69M | -598.87%-3.08M | ---8M | ---9.06M | ---8.59M |
| Noncontrolling interests | 2,166.67%68K | 6.86%109K | 12.24%55K | 68.94%223K | 527.27%69K | 200.00%3K | 168.42%102K | -39.51%49K | -53.19%132K | -83.33%11K |
| Net income attributable to the company | 68.05%12.88M | 30.42%11.71M | 336.98%8.57M | -25.35%19.87M | 2,280.25%6.85M | -44.77%7.66M | 6.17%8.98M | -178.55%-3.62M | 675.36%26.62M | 89.31%-314K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 68.05%12.88M | 30.42%11.71M | 336.98%8.57M | -25.35%19.87M | 2,280.25%6.85M | -44.77%7.66M | 6.17%8.98M | -178.55%-3.62M | 675.36%26.62M | 89.31%-314K |
| Diluted earnings per share | 75.00%0.21 | 35.71%0.19 | 333.33%0.14 | -24.39%0.31 | 0.11 | -42.86%0.12 | 7.69%0.14 | -185.71%-0.06 | 720.00%0.41 | 0 |
| Basic earnings per share | 75.00%0.21 | 35.71%0.19 | 333.33%0.14 | -24.39%0.31 | 0.11 | -42.86%0.12 | 7.69%0.14 | -185.71%-0.06 | 720.00%0.41 | 0 |
| Dividend per share | 14.29%0.1 | 0.00%0.0875 | 0.00%0.0875 | 0.00%0.35 | 0.00%0.0875 | 0.00%0.0875 | 0.00%0.0875 | 0.00%0.0875 | 0.00%0.35 | 0.00%0.0875 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.